Micronized vaginal progesterone to prevent miscarriage : a critical evaluation of randomized evidence
| dc.contributor.author | Coomarasamy, Arri | |
| dc.contributor.author | Devall, Adam J. | |
| dc.contributor.author | Brosens, Jan J. | |
| dc.contributor.author | Quenby, Siobhan | |
| dc.contributor.author | Stephenson, Mary D. | |
| dc.contributor.author | Sierra, Sony | |
| dc.contributor.author | Christiansen, Ole B. | |
| dc.contributor.author | Small, Rachel | |
| dc.contributor.author | Brewin, Jane | |
| dc.contributor.author | Roberts, Tracy E. | |
| dc.contributor.author | Dhillon-Smith, Rima | |
| dc.contributor.author | Harb, Hoda | |
| dc.contributor.author | Noordali, Hannah | |
| dc.contributor.author | Papadopoulou, Argyro | |
| dc.contributor.author | Eapen, Abey | |
| dc.contributor.author | Prior, Matt | |
| dc.contributor.author | Di Renzo, Gian Carlo | |
| dc.contributor.author | Hinshaw, Kim | |
| dc.contributor.author | Mol, Ben W. | |
| dc.contributor.author | Lumsden, Mary Ann | |
| dc.contributor.author | Khalaf, Yacoub | |
| dc.contributor.author | Shennan, Andrew | |
| dc.contributor.author | Goddijn, Mariette | |
| dc.contributor.author | van Wely, Madelon | |
| dc.contributor.author | Al-Memar, Maya | |
| dc.contributor.author | Bennett, Phil | |
| dc.contributor.author | Bourne, Tom | |
| dc.contributor.author | Rai, Raj | |
| dc.contributor.author | Regan, Lesley | |
| dc.contributor.author | Gallos, Ioannis D. | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Women’s Health Research | en |
| dc.date.accessioned | 2020-09-07T12:30:01Z | |
| dc.date.available | 2020-09-07T12:30:01Z | |
| dc.date.issued | 2020-08 | |
| dc.description | This PROMISE and PRISM trials were funded by the National Institute for Health Research (NIHR) (HTA 08/38/01 and HTA 12/167/26). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. This work was also supported by the Tommy’s charity to support the UK Miscarriage Research Network. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 729490 | |
| dc.identifier | 175215856 | |
| dc.identifier | 5d0ad9d8-68a9-412b-9ffd-62543017b0c8 | |
| dc.identifier | 85087113894 | |
| dc.identifier | 32008730 | |
| dc.identifier | 000556986200005 | |
| dc.identifier.citation | Coomarasamy, A, Devall, A J, Brosens, J J, Quenby, S, Stephenson, M D, Sierra, S, Christiansen, O B, Small, R, Brewin, J, Roberts, T E, Dhillon-Smith, R, Harb, H, Noordali, H, Papadopoulou, A, Eapen, A, Prior, M, Di Renzo, G C, Hinshaw, K, Mol, B W, Lumsden, M A, Khalaf, Y, Shennan, A, Goddijn, M, van Wely, M, Al-Memar, M, Bennett, P, Bourne, T, Rai, R, Regan, L & Gallos, I D 2020, 'Micronized vaginal progesterone to prevent miscarriage : a critical evaluation of randomized evidence', American Journal of Obstetrics and Gynecology, vol. 223, no. 2, pp. 167-176. https://doi.org/10.1016/j.ajog.2019.12.006 | en |
| dc.identifier.doi | 10.1016/j.ajog.2019.12.006 | |
| dc.identifier.iss | 2 | en |
| dc.identifier.issn | 0002-9378 | |
| dc.identifier.uri | https://hdl.handle.net/2164/15092 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85087113894&partnerID=8YFLogxK | en |
| dc.identifier.vol | 223 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | American Journal of Obstetrics and Gynecology | en |
| dc.subject | bleeding | en |
| dc.subject | luteal phase deficiency | en |
| dc.subject | meta-analysis | en |
| dc.subject | recurrent miscarriage | en |
| dc.subject | threatened miscarriage | en |
| dc.subject | vaginal micronized progesterone | en |
| dc.subject | Progesterone/administration & dosage | en |
| dc.subject | Humans | en |
| dc.subject | Administration, Intravaginal | en |
| dc.subject | Treatment Outcome | en |
| dc.subject | Abortion, Threatened/drug therapy | en |
| dc.subject | Pregnancy Trimester, First | en |
| dc.subject | Randomized Controlled Trials as Topic | en |
| dc.subject | Abortion, Habitual/prevention & control | en |
| dc.subject | Pregnancy | en |
| dc.subject | Progestins/administration & dosage | en |
| dc.subject | Female | en |
| dc.subject | TRIAL | en |
| dc.subject | WOMEN | en |
| dc.subject | LUTEAL-PHASE DEFECT | en |
| dc.subject | R Medicine | en |
| dc.subject | Obstetrics and Gynaecology | en |
| dc.subject.lcc | R | en |
| dc.title | Micronized vaginal progesterone to prevent miscarriage : a critical evaluation of randomized evidence | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Coomarasamy_etal_AJOG_Micronized_VOR.pdf
- Size:
- 712.39 KB
- Format:
- Adobe Portable Document Format
